China Grand Pharmaceutical and Healthcare Holdings Limited provided earnings guidance for the year ended 31 December 2018. The board of the directors of the Company announced that, based on the information currently available to the Company and the preliminary review by the management of the Company over the unaudited management accounts of the Group for the year ended 31 December 2018, it is expected that the consolidated net profit attributable to owners of the Company recorded an increase of not less than 40% as compared to that of the year ended 31 December 2017 (the audited consolidated net profit attributable to owners of the Company for the year ended 31 December 2018 amounted to approximately HKD 460,811,000).